Clinical Trials Directory

Trials / Unknown

UnknownNCT03720964

Mitochondrial Genetics of Presbycusis

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

The main goal of this study is to identify mitochondrial mutations associated with presbycusis. Patients affected by severe presbycusis and normal hearing controls (according to ISO7029 norm) will be enrolled if satisfying inclusion criteria (aged from 40 to 80 years old) in existing biocollections in the University Hospital of Angers. After DNA extraction, the mitochondrial genome will be sequenced and data in silico analysed.

Detailed description

The study will be proposed to patients consulting in the ENT department of the University Hospital of Angers. After clinical examination and audiometry recording, the eligibility criteria will be checked and inclusion in biocollections proposed. Presbycusis affected subjects will be enrolled in "Mitochondrial Disease biocollection" and normal hearing controls in "Healthy Volunteer biocollection". These biocollections have been approved by the board comitee "Centre de Protection des Personnes". After DNA extraction and mitochondrial sequencing, candidate variants will be selected by in silico analysis. The presence of mitochondrial variants in both groups (presbycusis and control) will be compared in multivariate analysis if needed. The nuclear DNA may be sequenced in order to complete the previous analysis and look for any candidate variant .

Conditions

Timeline

Start date
2019-04-01
Primary completion
2022-11-01
Completion
2023-11-01
First posted
2018-10-26
Last updated
2019-04-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03720964. Inclusion in this directory is not an endorsement.